- Home
- SCZM vs ORIC Comparison
SCZM vs ORIC Comparison
Compare SCZM & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SCZM | ORIC |
|---|---|---|
| Founded | N/A | 2014 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | SCZM | ORIC |
|---|---|---|
| Price | $9.99 | $9.98 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $19.73 |
| AVG Volume (30 Days) | 665.4K | ★ 1.4M |
| Earning Date | 01-29-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.67 | N/A |
| Revenue | ★ $305,267,000.00 | N/A |
| Revenue This Year | $13.70 | N/A |
| Revenue Next Year | $20.14 | N/A |
| P/E Ratio | $15.31 | ★ N/A |
| Revenue Growth | ★ 17.89 | N/A |
| 52 Week Low | $0.96 | $3.90 |
| 52 Week High | $17.65 | $14.93 |
Technical Indicators
Market Signals| Indicator | SCZM | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 30.91 | 47.73 |
| Support Level | $9.89 | $10.04 |
| Resistance Level | $12.20 | $11.08 |
| Average True Range (ATR) | 1.39 | 0.77 |
| MACD | -0.28 | -0.14 |
| Stochastic Oscillator | 4.92 | 22.79 |
Price Performance
Historical ComparisonAbout SCZM Santacruz Silver Mining Ltd. Common Shares
Santacruz Silver Mining Ltd is engaged in the operation, acquisition, exploration, and development of mineral properties in Latin America, with a primary focus on silver and zinc, including lead and copper. The company earns the majority of its revenue from Zinc and Silver. The company's reportable operating segments are the Bolivar mine and processing plant, the Porco mine and processing plant, the Caballo Blanco Group, San Lucas, Zimapan, and Corporate and Other activities. Key revenue is generated from Zimapan.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.